ORIC - Wall Street Estimates - ORIC Pharmaceuticals, Inc.

Healthcare - Biotechnology - NASDAQ - US

$ 9.58

-4.58 %

$ 676 M

Market Cap

-5.26

P/E

Price Target Average

103.55%

Revenue Forecast Estimate

-0.00%

EBIT Estimate

25.99%

Net Income Estimate

6.82%

WALL STREET ESTIMATES

Wall Street Analysts Price Targets ORIC Pharmaceuticals, Inc.

Wall Street analysts predict an average 1-year price target for ORIC of $19.5 , with forecasts ranging from a low of $17 to a high of $21 .

ORIC Lowest Price Target Wall Street Target

17 USD 77.45%

ORIC Average Price Target Wall Street Target

19.5 USD 103.55%

ORIC Highest Price Target Wall Street Target

21 USD 119.21%

REVENUE FORECAST

EBIT FORECAST

NET INCOME FORECAST

Free